Li N. Komatsu

Array ( [id] => 10297594 [patent_doc_number] => 20150182593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'COMPOSITION FOR TREATING HYPERLIPIDEMIA COMPRISING OXYNTOMODULIN DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 14/415200 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11457 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14662815 [patent_doc_number] => 10369284 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-06 [patent_title] => Kit, use thereof and method for filling connective tissue of the skin [patent_app_type] => utility [patent_app_number] => 14/417402 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 6654 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 216 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9307092 [patent_doc_number] => 20140045766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'NOVEL ANTI-AGING PEPTIDES AND COSMETIC AND/OR PHARMACEUTICAL COMPOSITION CONTAINING SAME' [patent_app_type] => utility [patent_app_number] => 13/935675 [patent_app_country] => US [patent_app_date] => 2013-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5309 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9517816 [patent_doc_number] => 20140154308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'Microparticle Formulations for Delivery to the Upper and Central Respiratory Tract and Methods of Manufacture' [patent_app_type] => utility [patent_app_number] => 13/931401 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21359 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13931401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263286 [patent_doc_number] => 20150148283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'NOVEL CASEIN PROTEIN PRODUCT' [patent_app_type] => utility [patent_app_number] => 14/409904 [patent_app_country] => US [patent_app_date] => 2013-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5970 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340455 [patent_doc_number] => 20150225460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT OF THE PULMONARY FORM OF ALTITUDE SICKNESS CAUSED BY LACK OF OXYGEN AND REDUCED AIR PRESSURE' [patent_app_type] => utility [patent_app_number] => 14/410642 [patent_app_country] => US [patent_app_date] => 2013-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11236 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414266 [patent_doc_number] => 20150299276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'Alpha-CONOTOXIN PEPTIDE, PHARMACEUTICAL COMPOSITION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/419584 [patent_app_country] => US [patent_app_date] => 2013-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 24198 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14419584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256341 [patent_doc_number] => 20150141338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-21 [patent_title] => 'DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 14/402540 [patent_app_country] => US [patent_app_date] => 2013-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5680 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13194127 [patent_doc_number] => 10111967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-30 [patent_title] => Complexes of RNA and cationic peptides for transfection and for immunostimulation [patent_app_type] => utility [patent_app_number] => 13/904868 [patent_app_country] => US [patent_app_date] => 2013-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 46482 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13904868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10241439 [patent_doc_number] => 20150126434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-07 [patent_title] => 'ANTIMICROBIAL PEPTIDE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/397920 [patent_app_country] => US [patent_app_date] => 2013-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5052 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202610 [patent_doc_number] => 20150087598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'TREATING MUC1-EXPRESSING CANCERS WITH HELICASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/397972 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 28900 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226820 [patent_doc_number] => 20150111813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN' [patent_app_type] => utility [patent_app_number] => 14/399588 [patent_app_country] => US [patent_app_date] => 2013-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26049 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14399588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926732 [patent_doc_number] => 20140329753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Angiogenic active lytic peptides' [patent_app_type] => utility [patent_app_number] => 13/986434 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 6646 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13986434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135537 [patent_doc_number] => 20130296252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'MUC18 TARGETING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/872908 [patent_app_country] => US [patent_app_date] => 2013-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18237 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8998705 [patent_doc_number] => 20130219829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'METHOD FOR THE PREPARATION OF A HEAT STABLE OXYGEN CARRIER-CONTAINING PHARMACEUTICAL COMPOSITION AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/855738 [patent_app_country] => US [patent_app_date] => 2013-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9137 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000348 [patent_doc_number] => 09044421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Treating MUC1-expressing cancers with combination therapies' [patent_app_type] => utility [patent_app_number] => 13/852390 [patent_app_country] => US [patent_app_date] => 2013-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 12117 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13852390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10607031 [patent_doc_number] => 09327050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-03 [patent_title] => 'Hemostatic material containing nano-fiber containing synthetic collagen' [patent_app_type] => utility [patent_app_number] => 13/848737 [patent_app_country] => US [patent_app_date] => 2013-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 8224 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269664 [patent_doc_number] => 20140024582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'STABLE INSULIN FORMULATIONS AND METHODS OF MAKING AND USING THEREOF' [patent_app_type] => utility [patent_app_number] => 13/848617 [patent_app_country] => US [patent_app_date] => 2013-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11001 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10213999 [patent_doc_number] => 20150098991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-09 [patent_title] => 'ORAL ADMINISTRATION' [patent_app_type] => utility [patent_app_number] => 14/385618 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15131 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977674 [patent_doc_number] => 09023985 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Glucagon composition' [patent_app_type] => utility [patent_app_number] => 13/834313 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13262 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13834313 [rel_patent_id] =>[rel_patent_doc_number] =>)